Skip to content

MEDI BELGIUM: what changed

BE 0469.031.028NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€422,510
2024 · €117,596+€304,915
Equity
€651,788
2024 · €1.0m-€377,490
Cash
€374,436
2024 · €308,152+€66,284
Balance sheet total
€1.7m
2024 · €1.8m-€78,326

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€101,187

    down €101,187 (-8.3%), from €1.2m to €1.1m

    of which Other amounts receivable: -€63,005

  • Cash +€66,284

    up €66,284 (+21.5%), from €308,152 to €374,436

    mainly Net result for the year (+€422,510) and Other debts (+€300,000)

  • Intangible fixed assets -€25,558

    down €25,558 (-15.6%), from €163,994 to €138,437

Equity and liabilities
  • Reserves -€380,000

    down €380,000 (-39.3%), from €966,200 to €586,200

    of which Distributable reserves: -€380,000

  • Other debts +€300,000

    new in 2025: €300,000

  • Trade debts -€33,422

    down €33,422 (-7.4%), from €449,048 to €415,626

  • Tax, wage and social debts +€29,950

    up €29,950 (+12.2%), from €245,851 to €275,801

    of which Remuneration and social security: +€19,961

Income statement
  • Gross operating margin +€427,692

    up €427,692 (+28.5%), from €1.5m to €1.9m

  • Staff costs +€142,799

    up €142,799 (+12.9%), from €1.1m to €1.3m

  • Taxes +€73,568

    up €73,568 (+84.8%), from €86,765 to €160,332

  • Write-downs -€60,674

    down €60,674 (-95.8%), from €63,311 to €2,636

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €117,596
Gross operating margin +€427,692
Staff costs -€142,799
Depreciation +€1,258
Write-downs +€60,674
Other operating charges +€7,410
Other operating items +€25,545
Financial income +€185
Financial charges -€1,483
Taxes -€73,568
Result 2025 €422,510
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€869,703
Investment -€3,419
Financing -€800,000
Cash 2024 €308,152
Net result for the year +€422,510
Depreciation +€41,071
Receivables within one year +€101,187
Deferred charges and accrued income +€5,770
Provisions +€2,636
Trade debts -€33,422
Tax, wage and social debts +€29,950
Other debts +€300,000
Investment in fixed assets (net) -€3,419
Contributions, distributions and other -€800,000
Cash 2025 €374,436
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,801,454 €1,723,128 -€78,326 -4.3%
Fixed assets 21/28 €264,716 €227,064 -€37,652 -14.2%
Intangible fixed assets 21 €163,994 €138,437 -€25,558 -15.6%
Tangible fixed assets 22/27 €66,647 €54,553 -€12,095 -18.1%
Plant, machinery and equipment 23 €5,776 €2,968 -€2,808 -48.6%
Other tangible fixed assets 26 €60,871 €51,584 -€9,287 -15.3%
Financial fixed assets 28 €34,075 €34,075 = 0.0%
Current assets 29/58 €1,536,738 €1,496,064 -€40,673 -2.6%
Amounts receivable within one year 40/41 €1,221,056 €1,119,869 -€101,187 -8.3%
Trade receivables 40 €1,146,835 €1,108,653 -€38,182 -3.3%
Other amounts receivable 41 €74,221 €11,216 -€63,005 -84.9%
Cash at bank and in hand 54/58 €308,152 €374,436 +€66,284 +21.5%
Deferred charges and accrued income 490/1 €7,529 €1,759 -€5,770 -76.6%
Total equity and liabilities 10/49 €1,801,454 €1,723,128 -€78,326 -4.3%
Equity 10/15 €1,029,277 €651,788 -€377,490 -36.7%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €966,200 €586,200 -€380,000 -39.3%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €960,000 €580,000 -€380,000 -39.6%
Profit (loss) carried forward 14 €1,077 €3,588 +€2,510 +233%
Provisions and deferred taxes 16 €77,278 €79,914 +€2,636 +3.4%
Provisions for liabilities and charges 160/5 €77,278 €79,914 +€2,636 +3.4%
Other liabilities and charges 164/5 €77,278 €79,914 +€2,636 +3.4%
Amounts payable 17/49 €694,899 €991,426 +€296,528 +42.7%
Amounts payable within one year 42/48 €694,899 €991,426 +€296,528 +42.7%
Trade debts 44 €449,048 €415,626 -€33,422 -7.4%
Suppliers 440/4 €449,048 €415,626 -€33,422 -7.4%
Taxes, remuneration and social security 45 €245,851 €275,801 +€29,950 +12.2%
Taxes 450/3 €20,390 €30,378 +€9,989 +49.0%
Remuneration and social security 454/9 €225,461 €245,422 +€19,961 +8.9%
Other amounts payable 47/48 - €300,000 +€300,000
Remuneration, social security and pensions 62 €1,107,364 €1,250,162 +€142,799 +12.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €42,329 €41,071 -€1,258 -3.0%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €63,311 €2,636 -€60,674 -95.8%
Other operating charges 640/8 €12,961 €5,551 -€7,410 -57.2%
Non-recurring operating charges 66A €30,363 €4,817 -€25,545 -84.1%
Gross operating margin 9900 €1,503,286 €1,930,978 +€427,692 +28.5%
Operating profit (loss) 9901 €246,959 €626,739 +€379,780 +154%
Financial income 75/76B €159 €344 +€185 +117%
Recurring financial income 75 €159 €344 +€185 +117%
Financial charges 65/66B €42,757 €44,241 +€1,483 +3.5%
Recurring financial charges 65 €42,757 €44,241 +€1,483 +3.5%
Profit (loss) for the period before taxes 9903 €204,361 €582,843 +€378,482 +185%
Income taxes 67/77 €86,765 €160,332 +€73,568 +84.8%
Profit (loss) for the period 9904 €117,596 €422,510 +€304,915 +259%
Profit (loss) for the period to be appropriated 9905 €117,596 €422,510 +€304,915 +259%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.3m to €1.7m

Midpoint €1.4m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €513,351
Capitalised earnings €2.0m to €2.9m
Indication €1.3m to €1.7m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€651,788
Intangible fixed assets (21)
-€138,437
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€513,351

Capitalised earnings

net result for the year (9904)
2025
€422,510
excluding non-recurring income and charges
€427,328
2024
€117,596
excluding non-recurring income and charges
€147,959
2023
€213,465
excluding non-recurring income and charges
€282,415
2022
€202,319
excluding non-recurring income and charges
€206,661
2021
€281,881
excluding non-recurring income and charges
€294,734
Average result, excluding non-recurring income and charges
€285,900
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€2.0m / €2.4m / €2.9m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 8 November 2026 via checked.be.